These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19876600)

  • 1. Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination.
    Passarin MG; Moretto G; Musso AM; Ottaviani S; Masotto B; Ghimenton C; Iuzzolino P; Buffone E; Rudà R; Soffietti R; Vattemi E; Pedersini R
    J Neurooncol; 2010 May; 97(3):439-44. PubMed ID: 19876600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide.
    Hoffmann AL; Buhk JH; Strik H
    Anticancer Res; 2009 Dec; 29(12):5191-5. PubMed ID: 20044635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine.
    Schaefer N; Rasch K; Moehlenbruch M; Urbach H; Stuplich M; Blasius E; Scheffler B; Herrlinger U; Glas M
    Acta Oncol; 2011 Nov; 50(8):1260-2. PubMed ID: 21736503
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: report of a unique case successfully treated with Temozolomide.
    Michotte A; Chaskis C; Sadones J; Veld PI; Neyns B
    J Neurol Sci; 2009 Dec; 287(1-2):267-70. PubMed ID: 19751941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal liposomal cytarabine and leptomeningeal medulloblastoma relapse: a valuable therapeutic option.
    Mastronuzzi A; Del Bufalo F; Iacono A; Secco DE; Serra A; Colafati GS; DE Ioris MA; Corsetti T
    Anticancer Res; 2013 Aug; 33(8):3515-8. PubMed ID: 23898128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide chemotherapy in recurrent oligodendroglioma.
    van den Bent MJ; Keime-Guibert F; Brandes AA; Taphoorn MJ; Kros JM; Eskens FA; Carpentier AF
    Neurology; 2001 Jul; 57(2):340-2. PubMed ID: 11468326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas.
    Brada M; Viviers L; Abson C; Hines F; Britton J; Ashley S; Sardell S; Traish D; Gonsalves A; Wilkins P; Westbury C
    Ann Oncol; 2003 Dec; 14(12):1715-21. PubMed ID: 14630674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child.
    Lassaletta A; Perez-Olleros P; Scaglione C; Sirvent S; De Prada I; Perez-Martinez A; Ruiz-Hernandez A; Madero L
    J Neurooncol; 2007 Jul; 83(3):303-6. PubMed ID: 17245619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide and cisplatin in the treatment of leptomeningeal metastatic involvement from melanoma: a case report.
    Salmaggi A; Silvani A; Eoli M; Lamperti E; Boiardi A
    Neurol Sci; 2002 Dec; 23(5):257-8. PubMed ID: 12528690
    [No Abstract]   [Full Text] [Related]  

  • 10. Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.
    Guillaume DJ; Doolittle ND; Gahramanov S; Hedrick NA; Delashaw JB; Neuwelt EA
    Neurosurgery; 2010 Jan; 66(1):48-58; discussion 58. PubMed ID: 20023537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas.
    Triebels VH; Taphoorn MJ; Brandes AA; Menten J; Frenay M; Tosoni A; Kros JM; Stege EB; Enting RH; Allgeier A; van Heuvel I; van den Bent MJ
    Neurology; 2004 Sep; 63(5):904-6. PubMed ID: 15365146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
    Singh E; Gurses ME; Costello MC; Berke C; Lu VM; Daggubati L; Komotar RJ; Ivan ME; Shah AH
    J Neurooncol; 2024 Mar; 167(1):39-47. PubMed ID: 38294637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.
    van den Bent MJ; Chinot O; Boogerd W; Bravo Marques J; Taphoorn MJ; Kros JM; van der Rijt CC; Vecht CJ; De Beule N; Baron B
    Ann Oncol; 2003 Apr; 14(4):599-602. PubMed ID: 12649108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.
    Chinot OL; Honore S; Dufour H; Barrie M; Figarella-Branger D; Muracciole X; Braguer D; Martin PM; Grisoli F
    J Clin Oncol; 2001 May; 19(9):2449-55. PubMed ID: 11331324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete durable response of a pediatric anaplastic oligodendroglioma to temozolomide alone: Case report and review of literature.
    Sorge C; Li R; Singh S; Reddy AT; Solomon DA; Perry A; Friedman GK
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28696020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131.
    Vogelbaum MA; Berkey B; Peereboom D; Macdonald D; Giannini C; Suh JH; Jenkins R; Herman J; Brown P; Blumenthal DT; Biggs C; Schultz C; Mehta M
    Neuro Oncol; 2009 Apr; 11(2):167-75. PubMed ID: 18779504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma.
    Ngo L; Nei M; Glass J
    Epilepsia; 2006 Jul; 47(7):1237-8. PubMed ID: 16886989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of liposomal cytarabine in children with primary CNS tumours with leptomeningeal involvement.
    Navajas A; Lassaletta A; Morales A; López-Ibor B; Sábado C; Moscardó C; Mateos E; Molina J; Sagaseta M; Sastre A
    Clin Transl Oncol; 2012 Apr; 14(4):280-6. PubMed ID: 22484635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal chemotherapy for leptomeningeal dissemination of medulloblastoma.
    Edwards MS; Levin VA; Seager ML; Wilson CB
    Childs Brain; 1981; 8(6):444-51. PubMed ID: 6796342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.